CIPLA (64)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply … | |||||||||||||||
NATCO Pharma provides clarification on ongoing litigation news, while Cipla addresses USFDA Form 483 inspectional observations at supply partner Pharmathen's Greece facility.
| |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner … | |||||||||||||||
NATCO Pharma clarifies ongoing litigation with no current material impact, while Cipla addresses USFDA Form 483 observations at partner facility Pharmathen manufacturing Lanreotide Injection.
| |||||||||||||||
BSE updates the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks across … | |||||||||||||||
BSE updates the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks across various sectors.
| |||||||||||||||
BSE has released the updated list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major … | |||||||||||||||
BSE has released the updated list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment, including major stocks like HDFC Bank, Infosys, Kotak Mahindra Bank, and JSW Steel.
| |||||||||||||||
BSE has updated the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment. | |||||||||||||||
BSE has updated the list of securities eligible for trading in the Securities Lending and Borrowing (SLB) segment.
| |||||||||||||||
NSE announces listing of further equity shares for 18 companies including ICICI Bank, Cipla, Coforge, and others, primarily under ESOP … | |||||||||||||||
NSE announces listing of further equity shares for 18 companies including ICICI Bank, Cipla, Coforge, and others, primarily under ESOP schemes, effective December 24, 2025.
| |||||||||||||||
BSE announces listing of additional shares issued under employee stock option schemes by 15 companies, including major banks and financial … | |||||||||||||||
BSE announces listing of additional shares issued under employee stock option schemes by 15 companies, including major banks and financial institutions, effective December 24, 2025.
| |||||||||||||||
BSE announces listing and admission to trading of further securities issued under ESOP/ESOS by 15 companies effective December 24, 2025. | |||||||||||||||
BSE announces listing and admission to trading of further securities issued under ESOP/ESOS by 15 companies effective December 24, 2025.
| |||||||||||||||
BSE announces listing and trading admission of equity shares issued under ESOP/ESOS schemes by 15 companies including ICICI Bank, Cipla, … | |||||||||||||||
BSE announces listing and trading admission of equity shares issued under ESOP/ESOS schemes by 15 companies including ICICI Bank, Cipla, Coforge, and others, effective December 24, 2025.
| |||||||||||||||
Updated position limits for derivatives trading including MWPL, client limits, proprietary limits, TM limits, FPI and MF limits across … | |||||||||||||||
Updated position limits for derivatives trading including MWPL, client limits, proprietary limits, TM limits, FPI and MF limits across multiple securities.
| |||||||||||||||